powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1043748205
Reem Al-Dallal
MD
Endocrinology
Houston,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 450068
Hospital
CCN 450184
Hospital
CCN 450289
Hospital
CCN 450610
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
97
Unique beneficiaries
—
Total services
125
Distinct HCPCS
5
Medicare payment
$9K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 484 Endocrinology providers in TX — bottom quintile (cohort median 868).
PRESCRIBING · PART D · 2024
Total Rx claims
1,040
Beneficiaries
—
Total drug cost
$508K
Distinct drugs
23
Brand share
46.2%
Top prescribed drugs
Semaglutide
136 claims
Levothyroxine Sodium
128 claims
Atorvastatin Calcium
73 claims
Insulin Glargine,hum.Rec.Anlog
70 claims
Metformin Hcl
69 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$199
Payment records
3
By payment type
Food and Beverage
$199
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
69.2
Cost
73.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.38%
Group
